Pharmacogenetics of anti-estrogen treatment of breast cancer
Keywords: مهار کننده آراماتاز; Tamoxifen; Aromatase inhibitor; CYP2D6; CYP19A1; Estrogen receptor; Polymorphisms; Pharmacogenetics